Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
出版年份 2021 全文链接
标题
Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 54, Issue 3, Pages 292-301
出版商
Wiley
发表日期
2021-06-21
DOI
10.1111/apt.16436
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
- (2020) Camilo Obando et al. ADVANCES IN THERAPY
- Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab
- (2020) Anne Hu et al. Clinical Gastroenterology and Hepatology
- Big data in IBD: a look into the future
- (2019) Pablo Olivera et al. Nature Reviews Gastroenterology & Hepatology
- Safety of drugs used for the treatment of Crohn’s disease
- (2019) Aviv Pudipeddi et al. Expert Opinion On Drug Safety
- Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)
- (2019) Anja Eberl et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
- (2019) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis
- (2019) Antje Mevius et al. DIGESTION
- Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
- (2018) Remo Panccione et al. GASTROENTEROLOGY
- Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
- (2018) Pei-Tzu Lin et al. Scientific Reports
- Treatment Persistence for Infliximab Versus Adalimumab in Crohnʼs Disease
- (2017) Pablo Olivera et al. INFLAMMATORY BOWEL DISEASES
- Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD
- (2017) Laura E. Targownik et al. INFLAMMATORY BOWEL DISEASES
- A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population
- (2017) Graeme Jones et al. International Journal of Rheumatic Diseases
- Review article: acute severe ulcerative colitis - evidence-based consensus statements
- (2016) J.-H. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologic agents for IBD: practical insights
- (2015) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis
- (2014) Rupert W.L. Leong et al. Journal of Crohns & Colitis
- Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
- (2014) Christopher Ma et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
- (2012) Christina Ha et al. Clinical Gastroenterology and Hepatology
- Medication Compliance and Persistence: Terminology and Definitions
- (2007) Joyce A. Cramer et al. VALUE IN HEALTH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started